Immune-stimulating potential of cell envelope proteins from Vibrio cholerae associated to chitosan microparticles: An in vitro study

References

• Aguado MT, Lambert PH. 1992. Controlled-release vaccines- biodegradable polylactide/polyglycolide (PL/PG) microsphere as antigen vehicles. Immunobiology, 184: 113–25.
   PubMed Web of Science ®Google Scholar
• Almeida AJ, Alpar HO, Brown MRW. 1993. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly (L-lactic acid) microspheres in rats, rabbits and guinea pigs. J Pharm Pharmacol, 45: 198–203.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, McKenzie IF. 2001. Role of the mannose receptor in the immune response. Curr Mol Med, 1: 469-74.
   PubMedGoogle Scholar
• Aranaz I, Mengibar M, Harris R, Panos I, Miralles B, Acosta N, . 2009. Functional characterization of chitin and chitosan. Curr Chem Biol, 3: 203–30.
   Google Scholar
• Azizi A, Ghunaim H, Diaz-Mitoma F, Mestecky J. 2010. Mucosal HIV vaccines: A holy grail or a dud?Vaccine, 28: 4015–26.
   Google Scholar
• Cleland JL, Barron L, Berman PW, Daugherty A, Gregory T, Lim A, . 1996. Development of single-shot subunit vaccine HIV-1:2 defining optimal auto boost characteristics to maximize the humoral response. J Pharm Sci, 85: 1346–49.
   PubMed Web of Science ®Google Scholar
• Draget KI. 1996. Association phenomenon in highly acetylated chitosan gel. Polym Gels Netw, 4: 143–51.
   Google Scholar
• East L, Isacke CM. 2002. The mannose receptor family. Biochim Biophys Acta, 1572: 364–86.
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Stass JK, Meulbroek JA, Tice TR, Gilley RM. 1991. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin- neutralizing antibodies. Infect Immun, 59: 2978–86.
   PubMed Web of Science ®Google Scholar
• Eyles J, Sharp G, Williamson E, Spiers I, Alpar H. 1998. Intranasal administration of polylactic acid microsphere coencapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine, 16: 698–707.
   PubMed Web of Science ®Google Scholar
• Fernandes PB, Smith HL. 1977. Effect of anaerobiosis and bile salts on the growth and toxin production by Vibrio cholerae. J Gen Microbiol, 98: 77–86.
   PubMedGoogle Scholar
• Lowry O, Rosebrough N. 1951. Protein measurement with the folin phenol reagent. J Biol Chem, 193: 265–275.
   PubMed Web of Science ®Google Scholar
• Manning PA, Imbesi F, Haynes DR. 1982. Cell envelope proteins in Vibrio cholerae. FEMS Microbiol Lett, 14: 159–66.
   Web of Science ®Google Scholar
• McGhee JR, Kiyono H. 1992. Mucosal immunity to vaccines: Current concepts for vaccine development and immune response analysis. Adv Exp Med Biol, 327: 3–12.
   PubMedGoogle Scholar
• McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M. 1992. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine, 10: 75–88.
   PubMed Web of Science ®Google Scholar
• McLaughlin JC. 1995. Vibrio. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds., Manual of clinical microbiology. Washington DC: ASM Press, 1995, 465–76.
   Google Scholar
• Men Y, Gander B, Merke HP, Corradin G. 1996. Induction of sustained and elevated immune response to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine, 14: 1442–50.
   PubMed Web of Science ®Google Scholar
• Mestecky J. 1987. The mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol, 7: 265–276.
   PubMed Web of Science ®Google Scholar
• Mi FL, Shyu SS, Chen CT, Schoung JY. 1999. Porous chitosan microspheres for controlling the antigen release of Newcastle disease vaccine: Preparation of antigen- adsorbed microsphere and in vitro release. Biomaterials, 20: 1603–12.
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. 1994. Microparticles as oral vaccines. Novel delivery system for oral vaccines.Boca Raton, FL: CRC Press, 175–205.
   Google Scholar
• O’Hagan DT, Jeffery H, Davis SS. 1993. Long term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine, 11: 965–69.
   PubMed Web of Science ®Google Scholar
• Park IK, Jiang HL, Yun CH, Choi YJ, Kim SJ, Akaike T, . 2004. Release of Newcastle disease virus from CMs in vitro and in vivo. Asian- Australas J Anim Sci, 17: 543–47.
   Web of Science ®Google Scholar
• Strand SP, Varum KM, Ostgaard K. 2003. Interactions between chitosans and bacterial suspensions: Adsorption and flocculation. Colloids Surf B, 27: 71–81.
   Web of Science ®Google Scholar
• Van der Lubben IM, Verhoef JC, Van Aelst AC, Borchard G, Junginger HE. 2001. Chitosan microparticles for oral vaccination: Preparation, characterization and preliminary in vivo uptake studies in murine Peyer’s patches. Biomaterials, 22: 687–694.
   PubMed Web of Science ®Google Scholar
• Verma RK, Misra A. 2008. Intracellular time course, pharmacokinetics and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Antimicrob Agents Chemother, 52: 3195–201.
   PubMed Web of Science ®Google Scholar
• Wang W, Liu X, Xie Y, Zhang H, Yu W, Xiong Y, . 2006. Microencapsulation using natural polysaccharides for drug delivery and cell implantation. J Mater Chem, 16: 3252–67.
   Web of Science ®Google Scholar
• World Health Organization. Cholera Fact Sheet. Available at http://www.who.int/mediacentre/factsheets/fs107/en/index.html. Accessed on 15 September 2011.
   Google Scholar
• Xu-Amano J, Beagley KW, Mega J, Fujihashi K, Kiyono H. 1992. Induction of T helper cells and cytokines for mucosal IgA responses. Adv Exp Med Biol, 327: 107–17.
   PubMedGoogle Scholar
• Xu YM, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm, 250: 215–26.
   PubMed Web of Science ®Google Scholar